Oxymatrine, the Main Alkaloid Component of Sophora Roots, Protects Heart against Arrhythmias in Rats

Abstract

Oxymatrine is one of the main alkaloid components extracted from Sophora roots and has been shown to play various protective roles in the cardiovascular system. The present study was designed to study the protective effect of oxymatrine on arrhythmias and their ionic channel mechanism. Rat arrhythmic models were established by aconitine injection and coronary artery ligation. Rat cardiomyocytes were acutely isolated, and the whole-cell patch clamp technique was employed to investigate the effects of oxymatrine on sodium channels. Pretreatment with oxymatrine markedly increased the dose of aconitine required to induce arrhythmias in rats. Additionally, oxymatrine significantly delayed the initial time and shortened the duration time of rat arrhythmias induced by coronary artery ligation. Cardiac mortality rate in coronary artery ligation-induced arrhythmias was also effectively decreased by oxymatrine in rats. The electrophysiological study showed that oxymatrine could significantly inhibit sodium and calcium currents in isolated rat cardiomyocytes in a concentration-dependent manner. In summary, oxymatrine plays a remarkably preventive role in rat arrhythmias through the inhibition of sodium and calcium currents.

Key words

oxymatrine - arrhythmias - sodium channel - calcium channel

References

• 1 Wu X N, Wang G J. Experimental studies of oxymatrine and its mechanisms of action in hepatitis B and C viral infections.  Chin J Dig Dis. 2004;  5 12-16
• 2 Song G, Luo Q, Qin J, Wang L, Shi Y, Sun C. Effects of oxymatrine on proliferation and apoptosis in human hepatoma cells.  Colloids Surf B Biointerfaces. 2006;  48 1-5
• 3 Chen Y X, Mao B Y, Jiang J H. Relationship between serum load of HBV-DNA and therapeutic effect of oxymatrine in patients with chronic hepatitis B.  Chin J Integr Tradit West Med. 2002;  22 335-336
• 4 Ding P L, Huang H, Zhou P, Chen D F. Quinolizidine alkaloids with anti-HBV activity from Sophora tonkinensis.  Planta Med. 2006;  72 854-856
• 5 Zhai D, Zhao Y, Chen X, Guo J, He H, Yu Q, Yang J, Davey A K, Wang J. Protective effect of glycyrrhizin, glycyrrhetic acid and matrine on acute cholestasis induced by alpha-naphthyl isothiocyanate in rats.  Planta Med. 2007;  73 128-133
• 6 Song M Q, Zhu J S, Chen J L, Wang L, Da W, Zhu L, Zhang W P. Synergistic effect of oxymatrine and angiogenesis inhibitor NM-3 on modulating apoptosis in human gastric cancer cells.  World J Gastroenterol. 2007;  13 1788-1793
• 7 Wang B, Wang G J, Xu J. Inhibitory effect of oxymatrine on vascular endothelial cell proliferation induced by tumor.  J Pract Oncol. 2000;  15 297-300
• 8 Zhao J, Yu S, Tong L, Zhang F, Jiang X, Pan S, Jiang H, Sun X. Oxymatrine attenuates intestinal ischemia/reperfusion injury in rats.  Surg Today. 2008;  38 931-937
• 9 Liu Y, Zhang X J, Yang C H, Fan H G. Oxymatrine protects rat brains against permanent focal ischemia and downregulates NF-kappaB expression.  Brain Res. 2009;  1268 174-180
• 10 Ma F, Li X P, Gu J C, Zhang L, Zheng L Z. Protective effects of oxymatrine on adriamycin-induced cardiotoxicity in rabbits and its mechanism.  J Shanghai Jiaotong Univ Med Sci. 2009;  29 685-688
• 11 Li Q, Wang J, Mao X J, Shao C L, Liu H, Wang S J. Studies on the cardiotonic activities of oxymatrine.  J Shenyang Pharm Univ. 1999;  4 281-284
• 12 Pan Z W, Wang Z Y, Du Z M, Jiao J D, Dong D L, Yang B F. Establishment of a novel arrhythmia model in rats.  Acta Pharm Sin. 2005;  40 659-662
• 13 Shan H L, Yang B F, Zhou Y H, Wang H, Li B X. Effects of matrine on aconitine-induced electrophysiological changes in rat ventricular myocytes.  J Chin Pharm Sci. 2004;  13 193-198
• 14 Ono M, Nakamura M, Koga K. KB-R9032, newly developed Na(+)/H(+) exchange inhibitor, attenuates reperfusion-induced arrhythmias in isolated perfused rat heart.  J Anesth. 2004;  18 196-202
• 15 Jurevichus J A, Rosenshtraukh L V. Mechanism of delayed afterdepolarization caused by aconitine.  Adv Myocardiol. 1982;  3 159-176
• 16 Amran M S, Hashimoto K, Homma N. Effects of sodium-calcium exchange inhibitors, KB-R7943 and SEA0400, on aconitine-induced arrhythmias in guinea pigs in vivo, in vitro, and in computer simulation studies.  J Pharmacol Exp Ther. 2004;  310 83-89
• 17 Kimura Y, Engelman R M, Rousou J, Flack J, Iyengar J, Das D K. Moderation of myocardial ischemia reperfusion injury by calcium channel and calmodulin receptor inhibition.  Heart Vessels. 1992;  7 189-195
• 18 Lazzara R, Scherlag B J. Generation of arrhythmias in myocardial ischemia and infarction.  Am J Cardiol. 1988;  61 20A-26A
• 19 Sharikabad M N, Aronsen J M, Haugen E, Pedersen J, Møller A S, Mørk H K, Aass H C, Sejersted O M, Sjaastad I, Brørs O. Cardiomyocytes from postinfarction failing rat hearts have improved ischemia tolerance.  Am J Physiol Heart Circ Physiol. 2009;  296 H787-H795
• 20 Cordeiro J M, Mazza M, Goodrow R, Ulahannan N, Antzelevitch C, Di Diego J M. Functionally distinct sodium channels in ventricular epicardial and endocardial cells contribute to a greater sensitivity of the epicardium to electrical depression.  Am J Physiol Heart Circ Physiol. 2008;  295 H154-H162
• 21 Williams I A, Xiao X H, Ju Y K, Allen D G. The rise of [Na(+)] (i) during ischemia and reperfusion in the rat heart-underlying mechanisms.  Pflugers Arch. 2007;  454 903-912
• 22 Yatani A, Brown A M, Schwartz A. Bepridil block of cardiac calcium and sodium channels.  J Pharmacol Exp Ther. 1986;  237 9-17
• 23 Scholtysik G, Imoto Y, Yatani A, Brown A M. 5-Hydroxytryptamine antagonist ICS 205–930 blocks cardiac potassium, sodium and calcium currents.  J Pharmacol Exp Ther. 1988;  245 773-778
• 24 Chang G J, Su M J, Hung L M, Lee S S. Cardiac electrophysiologic and antiarrhythmic actions of a pavine alkaloid derivative, O-methyl-neocaryachine, in rat heart.  Br J Pharmacol. 2002;  136 459-471
• 25 Wei J W, Liao J F, Chuang C Y, Chen C F, Han P W. Cardiovascular effects of matrine isolated from the Chinese herb Shan-dou-gen.  Proc Natl Sci Counc Repub China B. 1985;  9 215-219
• 26 Zhang B H, Wang N S, Li X J, Kong X J, Cai Y L. Anti-arrhythmic effects of matrine.  Acta Pharmacol Sin. 1990;  11 253-257
• 27 Xu C Q, Dong D L, Du Z M, Chen Q W, Gong D M, Yang B F. Comparison of the anti-arrhythmic effects of matrine and berbamine with amiodarone and RP58866.  Acta Pharm Sin. 2004;  39 691-694
• 28 Wang J M, Wang H P, Yu H D, Cheng L H. Determination and pharmacokinetic study of oxymatrine and its metabolite matrine in human plasma by liquid chromatography tandem mass spectrometry.  J Pharm Biomed Anal. 2006;  41 918-924